Login


TI Ref No : 516067554
Description : Medicines Containing The Active Ingredient Octreotide (atc: H01cb02 - Sustained-release Dosage Forms)
Date : 2025-03-21
Deadline : 2025-09-17
Document Type : Tenders
View Details
Whats app